| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8785420 | GALDERMA LABS | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(9 months ago) | |
| US8936800 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(9 months ago) | |
| US9814690 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(9 months ago) | |
| US8809305 | GALDERMA LABS | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec, 2022
(9 months ago) | |
| US8445543 | GALDERMA LABS | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(9 months ago) | |
| US9387187 | GALDERMA LABS | Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US9381179 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US8703820 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US8729127 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
Epiduo Forte is owned by Galderma Labs.
Epiduo Forte contains Adapalene; Benzoyl Peroxide.
Epiduo Forte has a total of 9 drug patents out of which 9 drug patents have expired.
Expired drug patents of Epiduo Forte are:
- US8785420
- US8936800
- US9814690
- US8809305
- US8445543
- US9387187
- US9381179
- US8703820
- US8729127
Epiduo Forte was authorised for market use on 15 July, 2015.
Epiduo Forte is available in gel;topical dosage forms.
Epiduo Forte can be used as treatment of acne.
The generics of Epiduo Forte are possible to be released after 12 March, 2023.
Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient
Market Authorisation Date: 15 July, 2015
Treatment: Treatment of acne
Dosage: GEL;TOPICAL
EPIDUO FORTE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic